Related Experiment Videos
Phospholipid-specific conformational changes in human prothrombin upon binding to procoagulant acidic lipid membranes
1Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill 27599.
Thrombosis and Haemostasis
|May 1, 1994
Summary
Human prothrombin changes its structure when binding to phosphatidylserine (PS) membranes. This conformational change is crucial for prothrombin activation, similar to findings in bovine prothrombin.
Area of Science:
- Biochemistry
- Molecular Biology
- Protein Structure
Background:
- Prothrombin activation is a critical step in blood coagulation.
- Procoagulant membranes, particularly those containing phosphatidylserine (PS), are known to accelerate this process.
- The precise molecular mechanisms underlying this acceleration are not fully understood.
Purpose of the Study:
- To investigate the conformational changes in human prothrombin upon binding to procoagulant membranes.
- To elucidate the role of phosphatidylserine (PS) in mediating these structural alterations.
- To compare these changes with those induced by other negatively-charged lipids.
Main Methods:
- Fourier transform infrared (FTIR) spectroscopy to analyze secondary structure.
- Differential scanning calorimetry (DSC) to study protein denaturation and domain organization.
- Utilized human prothrombin and prothrombin fragment 1.
Main Results:
- Human prothrombin exhibited a slight increase in ordered secondary structures (alpha-helix, beta-sheet, beta-turns) upon binding to PS-containing membranes.
- Differential scanning calorimetry revealed changes in the domain organization of prothrombin when bound to PS.
- Minimal structural changes were observed when prothrombin interacted with phosphatidylglycerol-containing membranes.
Conclusions:
- Binding to PS-containing membranes induces significant conformational changes in human prothrombin.
- These structural alterations are likely key to the cofactor-like role of platelet membrane vesicles in prothrombin activation.
- The findings support a molecular mechanism for enhanced prothrombin activation on specific membrane surfaces.